GlassScriptPhysician profile
Farah Naz
NPI 1457458259
$2,698.44
in general payments reported to CMS, 2019-2025
21 companies · $665 in 2025
The $665 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $957 · 2020: $208 · 2021: $179 · 2022: $31.24 · 2023: $532 · 2024: $126 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $776.81 | 2019-2023 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $402.39 | 2023-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $337.45 | 2019-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Acadia Pharmaceuticals INC | $249.99 | 2019 | |
| Neos Therapeutics, LP | $207.56 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $135.36 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $110.17 | 2023 | Farxiga |
| Merck Sharp & Dohme LLC | $105.93 | 2020-2024 | Vaxneuvance, Gardasil 9, Vaqta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.08 | 2019 | |
| Glaxosmithkline, LLC. | $43.14 | 2020-2022 | |
| Corium, LLC | $41.06 | 2023-2025 | Azstarys |
| Pfizer INC. | $36.33 | 2019-2024 | |
| Noven Therapeutics, LLC | $31.68 | 2025 | Xelstrym |
| Seqirus USA INC | $19.06 | 2024 | Flucelvax |
| Lnhc, INC | $19.05 | 2025 | Zelsuvmi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $16.74 | 2025 | Spinosad, Natroba |
| Phadia US INC. | $15.37 | 2021 | |
| Sanofi Pasteur INC. | $14.48 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.85 | 2025 | Zoryve |
| Adlon Therapeutics L.P. | $13.63 | 2019 | |
| Genentech USA, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farah Naz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.